Taffe, M.A. Funding: Blinding peer review. eLife, 2021;10:e74744 doi: 10.7554/eLife.74744 [ PubMed ]
Taffe, M.A., and Gilpin, N.W. The Funding is the Science: Racial Inequity of NIH Funding for Substance Use Disorder Topics Should Be Abolished. Drug and Alcohol Dependence, 2021. doi: 10.1016/j.drugalcdep.2021.109163
Gilpin, N.W. and Taffe, M.A. Toward an anti-racist approach to biomedical and neuroscience research. Journal of Neuroscience, 2021; 41(42): 8669-8672. doi: 10.1523/JNEUROSCI.1319-21.2021 [ PubMed ]
Taffe, M.A. and Gilpin, N.W. Racial inequity in grant funding from the US National Institutes of Health. eLife, 2021;10:e65697 doi: 10.7554/eLife.65697 [ Publisher Site ][ PubMed ]
Correspondence (peer reviewed): Taffe, M.A. NIH research funding disparities affect diversity, equity and inclusion goals of the ACNP , Neuropsychopharmacology, 2021 Jan29, doi: 10.1038/s41386-021-00969-9 [ PublisherSite ][ ReadCube (no paywall) ][ PubMed ]
Editorial: Taffe, M.A. and Olive, M.F. Designer drugs – A continuing chemical (R)evolution Neuropharmacology, 2018, 134(A):1-3 [ Publisher Site ][ PubMed ]
Review (peer reviewed): Boggs, D.L., Nguyen, J.D., Morgenson, D., Taffe, M.A. and Ranganathan, M. Clinical and Pre-Clinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol. Neuropsychopharmacology Reviews, 2018 Jan, 43(1):142-154. [ Publisher Site ][ PubMed ]
Review Chapter (peer reviewed): Aarde, S.M and Taffe, M.A. Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration. Current Topics in Behavioral Neurosciences, 2017, 32:145-164. DOI: http://dx.doi.org/10.1007/7854_2016_54 [ Publisher Site ][ PubMed ]
Taffe, M.A. Drug abuse scientists should use social media to engage the public because their primary translational product is information. Drug Alcohol Depend. 2015 Sep 1;154:315-9. [ Publisher Site ][ PubMed ]